UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis

Biomedicine & pharmacotherapy, 2020-04, Vol.124, p.109858

2020

Link zum Volltext

Verfügbarkeit prüfen

Retraction notice to “Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis” [Biomed. Pharmacother. 124 (2020) 109858]

Biomedicine & pharmacotherapy, 2023-04, Vol.160, p.114278-114278, Article 114278

2023

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of protein kinase CK2 sensitizes non-small cell lung cancer cells to cisplatin via upregulation of PML

Molecular and cellular biochemistry, 2017-12, Vol.436 (1-2), p.87-97

2017

Link zum Volltext

Verfügbarkeit prüfen

Metallothionein induction attenuates the progression of lung injury in mice exposed to long-term intermittent hypoxia

Inflammation research, 2020-01, Vol.69 (1), p.15-26

2020

Link zum Volltext

Verfügbarkeit prüfen

Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine

Frontiers in oncology, 2020-02, Vol.10, p.229-229

2020

Link zum Volltext

Verfügbarkeit prüfen

Coexistence of atypical adenomatous hyperplasia, minimally invasive adenocarcinoma and invasive adenocarcinoma: Gene mutation analysis

Thoracic cancer, 2021-03, Vol.12 (5), p.693-698

2021

Link zum Volltext

Verfügbarkeit prüfen

Whole exome sequencing of lung adenocarcinoma and lung squamous cell carcinoma in one individual: A case report

Thoracic cancer, 2020-08, Vol.11 (8), p.2361-2364

2020

Link zum Volltext

Verfügbarkeit prüfen

Follow‐up of an occult tuberculosis scar cancer after resection of metastatic lesions

Thoracic cancer, 2020-08, Vol.11 (8), p.2347-2350

2020

Link zum Volltext

Verfügbarkeit prüfen

[Retracted] miR‑154 suppresses non‑small cell lung cancer growth in vitro and in vivo

Oncology reports, 2023-06, Vol.49 (6), Article 121

2023

Link zum Volltext

Verfügbarkeit prüfen

Inhalation of Alcohol Vapor Driven by Oxygen is a Useful Therapeutic Method for Postoperative Alcohol Withdrawal Syndrome in a Patient with Esophageal Cancer: a Case Report

Alcohol and alcoholism (Oxford), 2011-07, Vol.46 (4), p.424-426

2011

Link zum Volltext

Verfügbarkeit prüfen

MiR-338-3p inhibits the growth and invasion of non-small cell lung cancer cells by targeting IRS2

American journal of cancer research, 2017, Vol.7 (1), p.53-63

2017

Link zum Volltext

Verfügbarkeit prüfen

Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial

The lancet respiratory medicine, 2021-09, Vol.9 (9), p.1021-1029

2021

Link zum Volltext

Verfügbarkeit prüfen

Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p

Bioscience reports, 2019-05, Vol.39 (5)

2019

Link zum Volltext

Verfügbarkeit prüfen

Interferon regulatory factor 6 correlates with the progression of non-small cell lung cancer and can be regulated by miR-320

Journal of pharmacy and pharmacology, 2021-03, Vol.73 (5), p.682-691

2021

Link zum Volltext

Verfügbarkeit prüfen

Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial

Journal of cancer research and clinical oncology, 2023-02, Vol.149 (2), p.819-831

2023

Link zum Volltext

Verfügbarkeit prüfen

miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2

Oncology letters, 2016-07, Vol.12 (1), p.301-306

2016

Link zum Volltext

Verfügbarkeit prüfen

miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo

Oncology reports, 2015-06, Vol.33 (6), p.3053-3060

2015

Link zum Volltext

Verfügbarkeit prüfen

[Retracted] miR‑154 inhibits migration and invasion of human non‑small cell lung cancer by targeting ZEB2

Oncology letters, 2021-08, Vol.22 (2), p.612-612, Article 612

2021

Link zum Volltext

Verfügbarkeit prüfen

RET fusion in advanced non-small-cell lung cancer and response to cabozantinib: A case report

Medicine (Baltimore), 2019-01, Vol.98 (3), p.e14120

2019

Link zum Volltext

Verfügbarkeit prüfen

Formononetin alleviates Streptococcus suis infection by targeting suilysin

Microbial pathogenesis, 2020-10, Vol.147, p.104388-104388, Article 104388

2020

Link zum Volltext

Verfügbarkeit prüfen

mi R-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2

Oncology letters, 2021-08, Vol.22 (2)

2021

Link zum Volltext

Verfügbarkeit prüfen

Asynchrony of primary tumor and mediastinal lymph nodes response after neoadjuvant immunotherapy plus chemotherapy in a patient with stage IIIA non-small-cell lung cancer: a case report

Anti-cancer drugs, 2022-01, Vol.33 (1), p.e784

2022

Link zum Volltext

Verfügbarkeit prüfen

Bilateral heterochronic spontaneous hemothorax caused by pulmonary arteriovenous malformation in a gravid: a case report

Journal of cardiothoracic surgery, 2010-10, Vol.5 (1), p.96-96, Article 96

2010

Link zum Volltext

Verfügbarkeit prüfen

RETRACTED: Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis

Biomedicine & pharmacotherapy, 2020-04, Vol.124, p.109858-109858, Article 109858

2020

Link zum Volltext

Verfügbarkeit prüfen

MiR-338-3p inhibits the growth and invasion of non-small cell lung cancer cells by targeting IRS2

American journal of cancer research, 2021-08, Vol.11 (8), p.4002-4004

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(33)
Humans
(16)
Oncology
(16)
Lung Cancer
(11)
Non-Small Cell Lung Cancer
(9)
Male
(8)
Lung Neoplasms - Pathology
(7)
Tumors
(7)
Animals
(6)
Carcinoma, Non-Small-Cell Lung - Pathology
(6)
Case Report
(6)
Female
(6)
Respiratory System
(6)
Surgery
(6)
Technology
(6)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(5)
Case Reports
(5)
Metastasis
(5)
Middle Aged
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis

Retraction notice to “Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis” [Biomed. Pharmacother. 124 (2020) 109858]

Inhibition of protein kinase CK2 sensitizes non-small cell lung cancer cells to cisplatin via upregulation of PML

Metallothionein induction attenuates the progression of lung injury in mice exposed to long-term intermittent hypoxia

Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine

Coexistence of atypical adenomatous hyperplasia, minimally invasive adenocarcinoma and invasive adenocarcinoma: Gene mutation analysis

Whole exome sequencing of lung adenocarcinoma and lung squamous cell carcinoma in one individual: A case report

Follow‐up of an occult tuberculosis scar cancer after resection of metastatic lesions

[Retracted] miR‑154 suppresses non‑small cell lung cancer growth in vitro and in vivo

Inhalation of Alcohol Vapor Driven by Oxygen is a Useful Therapeutic Method for Postoperative Alcohol Withdrawal Syndrome in a Patient with Esophageal Cancer: a Case Report

MiR-338-3p inhibits the growth and invasion of non-small cell lung cancer cells by targeting IRS2

Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial

Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p

Interferon regulatory factor 6 correlates with the progression of non-small cell lung cancer and can be regulated by miR-320

Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial

miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2

miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo

[Retracted] miR‑154 inhibits migration and invasion of human non‑small cell lung cancer by targeting ZEB2

RET fusion in advanced non-small-cell lung cancer and response to cabozantinib: A case report

Formononetin alleviates Streptococcus suis infection by targeting suilysin

mi R-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2

Asynchrony of primary tumor and mediastinal lymph nodes response after neoadjuvant immunotherapy plus chemotherapy in a patient with stage IIIA non-small-cell lung cancer: a case report

Bilateral heterochronic spontaneous hemothorax caused by pulmonary arteriovenous malformation in a gravid: a case report

RETRACTED: Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis

MiR-338-3p inhibits the growth and invasion of non-small cell lung cancer cells by targeting IRS2

Suchergebnisse filtern